Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Exchange Rate Effect (2016 - 2017)

Historic Exchange Rate Effect for United Therapeutics (UTHR) over the last 9 years, with Q3 2017 value amounting to -$200000.0.

  • United Therapeutics' Exchange Rate Effect rose 8000.0% to -$200000.0 in Q3 2017 from the same period last year, while for Dec 2017 it was -$1.4 million, marking a year-over-year increase of 5333.33%. This contributed to the annual value of $200000.0 for FY2017, which is 10666.67% up from last year.
  • Per United Therapeutics' latest filing, its Exchange Rate Effect stood at -$200000.0 for Q3 2017, which was up 8000.0% from -$200000.0 recorded in Q4 2016.
  • United Therapeutics' Exchange Rate Effect's 5-year high stood at $1.5 million during Q2 2015, with a 5-year trough of -$3.1 million in Q1 2015.
  • For the 5-year period, United Therapeutics' Exchange Rate Effect averaged around -$742294.1, with its median value being -$295000.0 (2013).
  • Over the last 5 years, United Therapeutics' Exchange Rate Effect had its largest YoY gain of 37468.35% in 2015, and its largest YoY loss of 191298.7% in 2015.
  • Over the past 5 years, United Therapeutics' Exchange Rate Effect (Quarter) stood at -$295000.0 in 2013, then crashed by 892.54% to -$2.9 million in 2014, then surged by 45.36% to -$1.6 million in 2015, then surged by 87.5% to -$200000.0 in 2016, then changed by 0.0% to -$200000.0 in 2017.
  • Its Exchange Rate Effect stands at -$200000.0 for Q3 2017, versus -$200000.0 for Q4 2016 and -$1.0 million for Q3 2016.